Profile
Matthew McAviney is currently Director at Jamanda Ltd., Non-Executive Director at AviadoBio Ltd., and Partner at Monograph Capital Advisors (UK) LLP starting in 2026.
Formerly, Dr. McAviney was Director at Polyneuron Pharmaceuticals AG; Partner at NEA Management Co. LLC from 2018 to 2026; Principal at F-Prime, Inc. from 2013 to 2018; Senior Equity Research Associate & Biotechnology at Robert W.
Baird & Co., Inc. (Broker) from 2011 to 2012; and Associate, Health & Life Sciences Practice at Oliver, Wyman & Co. LLC from 2012 to 2013.
Education includes an undergraduate degree from The University of Chicago in 2006, a doctorate from the University of Illinois in 2011, and an MBA from the University of Chicago Booth School of Business in 2011.
Matthew McAviney active positions
| Companies | Position | Start |
|---|---|---|
Jamanda Ltd.
Jamanda Ltd. Financial ConglomeratesFinance Functions as an investment holding company | Director/Board Member | - |
AviadoBio Ltd.
AviadoBio Ltd. Pharmaceuticals: MajorHealth Technology Develops medicines for frontotemporal dementia and amyotrophic lateral sclerosis | Director/Board Member | - |
Monograph Capital Advisors (UK) LLP
Monograph Capital Advisors (UK) LLP Investment ManagersFinance Monograph Capital invests in companies located in the United Kingdom. The firm targets companies operating in the fields of the biotechnology and healthcare sectors. It provides financing for early and growth stage capital requirements. | Private Equity Investor | 31/03/2026 |
Former positions of Matthew McAviney
| Companies | Position | End |
|---|---|---|
NEA Management Co. LLC
NEA Management Co. LLC Investment ManagersFinance New Enterprise Associates seeks invests in companies located across the globe. The firm targets companies operating in the fields of technology (software & services, systems, consumer & internet, energy), healthcare (biopharms, devices, services). The firm provides financing for seed, early and growth stage capital requirements. | Private Equity Investor | 30/03/2026 |
Impresa Management LLC
Impresa Management LLC Investment ManagersFinance F-Prime invests in companies located in Asia, Europe, North America, and South America. The firm focuses on companies operating in the life sciences, technology, healthtech services, and crypto sectors. It provides financing for seed, early, and later stage capital requirements. | Private Equity Investor | 31/05/2018 |
Oliver, Wyman & Co. LLC | Private Equity Analyst | 31/08/2013 |
Robert W. Baird & Co., Inc. (Broker)
Robert W. Baird & Co., Inc. (Broker) Investment Banks/BrokersFinance Provides brokerage services | Private Equity Analyst | 31/07/2012 |
Polyneuron Pharmaceuticals AG
Polyneuron Pharmaceuticals AG Pharmaceuticals: MajorHealth Technology Develops drugs for the treatment of autoimmune disorders | Director/Board Member | - |
Training of Matthew McAviney
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 10 |
|---|---|
Robert W. Baird & Co., Inc. (Broker)
Robert W. Baird & Co., Inc. (Broker) Investment Banks/BrokersFinance Provides brokerage services | Finance |
NEA Management Co. LLC
NEA Management Co. LLC Investment ManagersFinance New Enterprise Associates seeks invests in companies located across the globe. The firm targets companies operating in the fields of technology (software & services, systems, consumer & internet, energy), healthcare (biopharms, devices, services). The firm provides financing for seed, early and growth stage capital requirements. | Finance |
The University of Chicago
The University of Chicago Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Illinois
University of Illinois Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Oliver, Wyman & Co. LLC | |
Impresa Management LLC
Impresa Management LLC Investment ManagersFinance F-Prime invests in companies located in Asia, Europe, North America, and South America. The firm focuses on companies operating in the life sciences, technology, healthtech services, and crypto sectors. It provides financing for seed, early, and later stage capital requirements. | Finance |
Polyneuron Pharmaceuticals AG
Polyneuron Pharmaceuticals AG Pharmaceuticals: MajorHealth Technology Develops drugs for the treatment of autoimmune disorders | Health Technology |
Jamanda Ltd.
Jamanda Ltd. Financial ConglomeratesFinance Functions as an investment holding company | Finance |
AviadoBio Ltd.
AviadoBio Ltd. Pharmaceuticals: MajorHealth Technology Develops medicines for frontotemporal dementia and amyotrophic lateral sclerosis | Health Technology |
Monograph Capital Advisors (UK) LLP
Monograph Capital Advisors (UK) LLP Investment ManagersFinance Monograph Capital invests in companies located in the United Kingdom. The firm targets companies operating in the fields of the biotechnology and healthcare sectors. It provides financing for early and growth stage capital requirements. | Finance |
- Stock Market
- Insiders
- Matthew McAviney
















